BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 13680324)

  • 1. Voriconazole for invasive aspergillosis in oncohematological patients: a single-center pediatric experience.
    Cesaro S; Strugo L; Alaggio R; Cecchetto G; Rigobello L; Pillon M; Cusinato R; Zanesco L
    Support Care Cancer; 2003 Nov; 11(11):722-7. PubMed ID: 13680324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis.
    Cesaro S; Toffolutti T; Messina C; Calore E; Alaggio R; Cusinato R; Pillon M; Zanesco L
    Eur J Haematol; 2004 Jul; 73(1):50-5. PubMed ID: 15182338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
    Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L
    J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofungin.
    Raad II; Hanna HA; Boktour M; Jiang Y; Torres HA; Afif C; Kontoyiannis DP; Hachem RY
    Leukemia; 2008 Mar; 22(3):496-503. PubMed ID: 18094720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral voriconazole versus intravenous low dose amphotericin B for primary antifungal prophylaxis in pediatric acute leukemia induction: a prospective, randomized, clinical study.
    Mandhaniya S; Swaroop C; Thulkar S; Vishnubhatla S; Kabra SK; Xess I; Bakhshi S
    J Pediatr Hematol Oncol; 2011 Dec; 33(8):e333-41. PubMed ID: 22042283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Case report: Invasive aspergillosis successfully treated with voriconazole without recurrence during subsequent bone marrow transplantation.
    Chow E; Moore T; Nielsen K
    Pediatr Infect Dis J; 2003 Dec; 22(12):1109-10. PubMed ID: 14688580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical voriconazole solution for cutaneous aspergillosis in a pediatric patient after bone marrow transplant.
    Klein KC; Blackwood RA
    Pediatrics; 2006 Aug; 118(2):e506-8. PubMed ID: 16816005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children.
    Walsh TJ; Lutsar I; Driscoll T; Dupont B; Roden M; Ghahramani P; Hodges M; Groll AH; Perfect JR
    Pediatr Infect Dis J; 2002 Mar; 21(3):240-8. PubMed ID: 12005089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
    Mattei D; Mordini N; Lo Nigro C; Ghirardo D; Ferrua MT; Osenda M; Gallamini A; Bacigalupo A; Viscoli C
    Bone Marrow Transplant; 2002 Dec; 30(12):967-70. PubMed ID: 12476292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
    Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
    Haematologica; 1997; 82(3):297-304. PubMed ID: 9234575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voriconazole: new preparation. Invasive aspergillosis: benefits to be confirmed.
    Prescrire Int; 2004 Feb; 13(69):13-6. PubMed ID: 15055210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis.
    Sambatakou H; Dupont B; Lode H; Denning DW
    Am J Med; 2006 Jun; 119(6):527.e17-24. PubMed ID: 16750972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
    Herbrecht R; Denning DW; Patterson TF; Bennett JE; Greene RE; Oestmann JW; Kern WV; Marr KA; Ribaud P; Lortholary O; Sylvester R; Rubin RH; Wingard JR; Stark P; Durand C; Caillot D; Thiel E; Chandrasekar PH; Hodges MR; Schlamm HT; Troke PF; de Pauw B;
    N Engl J Med; 2002 Aug; 347(6):408-15. PubMed ID: 12167683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Voriconazole induced bradycardia.
    Uludağ D; Ozdemir N; Tüysüz G; Eroğlu AG; Celkan T
    Pediatr Hematol Oncol; 2013 Oct; 30(7):674-6. PubMed ID: 23484777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?
    Pagano L; Valentini CG; Fianchi L; Caira M
    J Chemother; 2011 Feb; 23(1):5-8. PubMed ID: 21482486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Successful treatment of neuroaspergillosis in a patient with acute lymphoblastic leukemia: role of surgery, systemic antifungal therapy and intracavitary therapy].
    Ozçelik T; Ozkalemkaş F; Kocaeli H; Altundal Y; Ener B; Ali R; Ozkocaman V; Hakyemez B; Tunali A
    Mikrobiyol Bul; 2009 Jul; 43(3):499-506. PubMed ID: 19795628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Invasive aspergillosis in haematological malignancies: clinical findings and management for intensive chemotherapy completion.
    Nosari A; Oreste P; Cairoli R; Montillo M; Carrafiello G; Astolfi A; Muti G; Marbello L; Tedeschi A; Magliano E; Morra E
    Am J Hematol; 2001 Dec; 68(4):231-6. PubMed ID: 11754411
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid improvement of disseminated aspergillosis with caspofungin/voriconazole combination in an adult leukemic patient.
    Damaj G; Ivanov V; Le Brigand B; D'incan E; Doglio MF; Bilger K; Faucher C; Vey N; Gastaut JA
    Ann Hematol; 2004 Jun; 83(6):390-3. PubMed ID: 14666380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antifungal therapy in febrile neutropenic patients: review of treatment choices and strategies for aspergillar infection.
    Klastersky J; Paesmans M
    Support Care Cancer; 2007 Feb; 15(2):137-41. PubMed ID: 16967301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of disseminated aspergillosis with voriconazole/liposomal amphotericin B in a child with leukemia.
    Athanassiadou F; Tragiannidis A; Kourti M; Papageorgiou T; Velegraki A; Kalogera A
    Pediatr Blood Cancer; 2005 Dec; 45(7):1003-4. PubMed ID: 16047372
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.